Article
Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.
Antimicrobial agents and chemotherapy - 1 Jan 2005
Crespan Emmanuele, Locatelli Giada A, Cancio Reynel, Hübscher Ulrich, Spadari Silvio, Maga Giovanni
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) derivatives with D113E, Y115F, F116Y, Q151E/N, and M184V mutations were studied for their phosphorolysis-mediated resistance to the nucleoside RT inhibitors (NRTIs) zidovudine and stavudine and for their inhibition by the nonnucleoside analogs (NNRTIs) efavirenz and nevirapine. The results presented here indicate that these single amino acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.